Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) traded down 6.7% on Thursday . The company traded as low as GBX 42.77 and last traded at GBX 46.67. Approximately 386,473 shares traded hands during mid-day trading, an increase of 152% from the average session volume of 153,287 shares. The stock had previously closed at GBX 50.
Beximco Pharmaceuticals Price Performance
The firm has a market capitalization of £208.22 million, a P/E ratio of 0.03 and a beta of 0.61. The business’s fifty day moving average is GBX 42.86 and its 200 day moving average is GBX 42.70. The company has a current ratio of 4.13, a quick ratio of 0.37 and a debt-to-equity ratio of 5.27.
About Beximco Pharmaceuticals
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.
See Also
- Five stocks we like better than Beximco Pharmaceuticals
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
